Share Twitter LinkedIn Facebook Email Aaron Gerds, MD of @CleClinicMD discusses the phase 2 study of luspatercept in patients with myelofibrosis-associated anemia
Spotlight on Myelofibrosis 2024: The Critical Evolution of JAK Inhibitors Myeloproliferative Disease 3 Mins Read
